Pesquisas alternativas:
compas » compass (Expandir a Pesquisa)
pml » pmol (Expandir a Pesquisa)
camp » cam (Expandir a Pesquisa), cap (Expandir a Pesquisa), came (Expandir a Pesquisa)
netw » new (Expandir a Pesquisa), net (Expandir a Pesquisa), neto (Expandir a Pesquisa)
compas » compass (Expandir a Pesquisa)
pml » pmol (Expandir a Pesquisa)
camp » cam (Expandir a Pesquisa), cap (Expandir a Pesquisa), came (Expandir a Pesquisa)
netw » new (Expandir a Pesquisa), net (Expandir a Pesquisa), neto (Expandir a Pesquisa)
1
“... was searched to review recent pharmacodynamic and clinical studies evaluating besifloxacin and comparing...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Price, Gregory L., Davis, Keith L., Karve, Sudeep, Pohl, Gerhardt, Walgren, Richard A.
Publicado em 2014
“...PURPOSE: Non-CML myeloproliferative neoplasms (MPN) include essential thrombocythemia (ET...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“.... These experiments show that continuous culture with TCGF can expand a variety of T-cell subpopulations...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Saito, Ângela, Souza, Edmarcia E., Costa, Fernanda C., Meirelles, Gabriela V., Gonçalves, Kaliandra A., Santos, Marcos T., Bressan, Gustavo C., McComb, Mark E., Costello, Catherine E., Whelan, Stephen A., Kobarg, Jörg
Publicado no J Proteome Res (2017)
“...-type or their non-SUMOylated triple-mutants, the average number of PML-nuclear bodies (PML-NBs...”Publicado no J Proteome Res (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Newell, Laura F., Gooley, Ted, Hansen, John A., Stirewalt, Derek L., Petersdorf, Effie W., Deeg, H. Joachim
Publicado em 2010
“... a high prevalence of HLA-DR15 and express high levels of TNF in the bone marrow. The present...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Nakahara, Jin, Tomaske, Laura, Kume, Kodai, Takata, Tadayuki, Kamada, Masaki, Deguchi, Kazushi, Kufukihara, Kenji, Schneider, Ruth, Gold, Ralf, Ayzenberg, Ilya
Publicado no Neurol Neuroimmunol Neuroinflamm (2019)
“... supratentorial and infratentorial lesions and a pronounced disability. Diagnosis can be challenging because PML...”Publicado no Neurol Neuroimmunol Neuroinflamm (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Copelan, Edward A., Avalos, Belinda, Ahn, Kwang Woo, Zhu, Xiaochun, Gale, Robert Peter, Grunwald, Michael R., Hamadani, Mehdi, Hamilton, Betty K., Hale, Gregory A., Marks, David I., Waller, Edmund K., Savani, Bipin N., Costa, Luciano J., Ramanathan, Muthalagu, Cahn, Jean-Yves, Khoury, H. Jean, Weisdorf, Daniel J., Inamoto, Yoshihiro, Kamble, Rammurti T., Schouten, Harry C., Wirk, Baldeep, Litzow, Mark R., Aljurf, Mahmoud D., van Besien, Koen W., Ustun, Celalettin, Bolwell, Brian J., Bredeson, Christopher N., Fasan, Omotayo, Ghosh, Nilanjan, Horowitz, Mary M., Arora, Mukta, Szer, Jeffrey, Loren, Alison W., Alyea, Edwin P., Cortes, Jorge, Maziarz, Richard T., Kalaycio, Matt E., Saber, Wael
Publicado no Biol Blood Marrow Transplant (2014)
“... compared to TBI (RR=0.36; P=0.022) or oral Bu (RR=0.39; P=0.028), but non-relapse mortality and survival...”Publicado no Biol Blood Marrow Transplant (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“... compared with the non-diabetic non-obese group. A significant positive correlation was found between CML...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Ponce, D. M., Hilden, P., Devlin, S.M., Maloy, M., Lubin, M., Castro-Malaspina, H., Dahi, P., Hsu, K., Jakubowski, A. A., Kernan, N. A., Koehne, G., O’Reilly, R. J., Papadopoulos, E. B., Perales, M. A., Sauter, C., Scaradavou, A., Tamari, R., van den Brink, M.R.M., Young, J. W., Giralt, S., Barker, J. N.
Publicado no Biol Blood Marrow Transplant (2015)
“... depleted URDT (HR 1.91, p = 0.037). High DFS can be achieved in adults with acute leukemia and CML with low...”Publicado no Biol Blood Marrow Transplant (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Iacobaeus, Ellen, Burkill, Sarah, Bahmanyar, Shahram, Hakim, Ramil, Byström, Camilla, Fored, Michael, Olsson, Tomas, Brundin, Lou, Montgomery, Scott
Publicado no Neurology (2018)
“... of PML increased from a largely stable level at 0.026 (95% confidence interval [CI] 0.021–0.031) per...”Publicado no Neurology (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“... tissues obtained from non-Hodgkin’s lymphoma patients. A link between SV40 and NHL is biologically...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Dammag, Enas A., Hamed, Nahla A. M., Elhalawani, Nabil A., Kassem, Heba S., Ayad, Mona W.
Publicado no Indian J Hematol Blood Transfus (2019)
“... was mainly wild in CML (65.4%) and control (63.3%) groups compared to AML as wild was only in (46...”Publicado no Indian J Hematol Blood Transfus (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... multifocal leukoencephalopathy (PML), with a 23% mortality rate. Risk stratification on the basis...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Dong-Si, Tuan, Richman, Sandra, Wattjes, Mike P, Wenten, Made, Gheuens, Sarah, Philip, Jeffrey, Datta, Shoibal, McIninch, James, Bozic, Carmen, Bloomgren, Gary, Richert, Nancy
Publicado no Ann Clin Transl Neurol (2014)
“..., and at 6 and 12 months post-diagnosis. RESULTS: A total of 372 PML cases were analyzed; 30 patients were...”Publicado no Ann Clin Transl Neurol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Wang, J, Hughes, T P, Kok, C H, Saunders, V A, Frede, A, Groot-Obbink, K, Osborn, M, Somogyi, A A, D'Andrea, R J, White, D L
Publicado em 2012
“... lower viable cell number compared with imatinib alone. In contrast, ibuprofen led to a significant...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Harrach, S, Schmidt-Lauber, C, Pap, T, Pavenstädt, H, Schlatter, E, Schmidt, E, Berdel, W E, Schulze, U, Edemir, B, Jeromin, S, Haferlach, T, Ciarimboli, G, Bertrand, J
Publicado no Blood Cancer J (2016)
“... is reduced in total bone marrow cells of imatinib-non-responding CML patients compared with imatinib...”Publicado no Blood Cancer J (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Toman, O., Kabickova, T., Vit, O., Fiser, R., Polakova, K. Machova, Zach, J., Linhartova, J., Vyoral, D., Petrak, J.
Publicado no Oncol Rep (2016)
“... that Ca(2+) homeostasis can be a potential therapeutic target in CML cells resistant to TKIs. We...”Publicado no Oncol Rep (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
Por Fissolo, Nicolás, Pignolet, Beatrice, Rio, Jordi, Vermersch, Patrick, Ruet, Aurélie, deSèze, Jerome, Labauge, Pierre, Vukusic, Sandra, Papeix, Caroline, Martinez-Almoyna, Laurent, Tourbah, Ayman, Clavelou, Pierre, Moreau, Thibault, Pelletier, Jean, Lebrun-Frenay, Christine, Bourre, Bertrand, Defer, Gilles, Montalban, Xavier, Brassat, David, Comabella, Manuel
Publicado no Neurol Neuroimmunol Neuroinflamm (2021)
“...); (2) a cohort of patients whose blood was collected during PML; (3) an independent cohort of non-PML...”Publicado no Neurol Neuroimmunol Neuroinflamm (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Ryerson, Lana Zhovtis, Foley, John, Chang, Ih, Kister, Ilya, Cutter, Gary, Metzger, Ryan R., Goldberg, Judith D., Li, Xiaochun, Riddle, Evan, Smirnakis, Karen, Kasliwal, Rachna, Ren, Zheng, Hotermans, Christophe, Ho, Pei-Ran, Campbell, Nolan
Publicado no Neurology (2019)
“...) program to compare progressive multifocal leukoencephalopathy (PML) risk with natalizumab extended...”Publicado no Neurology (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Singh, Balraj, Ayad, Sarah, Kaur, Parminder, Kumar, Vinod, Gupta, Sachin, Maroules, Michael
Publicado no Eur J Case Rep Intern Med (2021)
“... disease 2019 (COVID-19), has caused a global health crisis. COVID-19 can have a multifaceted presentation...”Publicado no Eur J Case Rep Intern Med (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo